Germany Biopharmaceutical Excipients Market Size & Outlook

The biopharmaceutical excipients market in Germany is expected to reach a projected revenue of US$ 283.4 million by 2030. A compound annual growth rate of 5.3% is expected of Germany biopharmaceutical excipients market from 2024 to 2030.
Revenue, 2023 (US$M)
$197.2
Forecast, 2030 (US$M)
$283.4
CAGR, 2024 - 2030
5.3%
Report Coverage
Germany

Germany biopharmaceutical excipients market, 2018-2030 (US$M)

Germany

Germany biopharmaceutical excipients market highlights

  • The Germany biopharmaceutical excipients market generated a revenue of USD 197.2 million in 2023 and is expected to reach USD 283.4 million by 2030.
  • The Germany market is expected to grow at a CAGR of 5.3% from 2024 to 2030.
  • In terms of segment, carbohydrates was the largest revenue generating product in 2023.
  • Polyols is the most lucrative product segment registering the fastest growth during the forecast period.


Biopharmaceutical excipients market data book summary

Market revenue in 2023USD 197.2 million
Market revenue in 2030USD 283.4 million
Growth rate5.3% (CAGR from 2023 to 2030)
Largest segmentCarbohydrates
Fastest growing segmentPolyols
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationSpecialty Excipients/Others, Solubilizes & Surfactants/Emulsifiers, Polyols, Carbohydrates
Key market players worldwideMerck KGaA, Basf SE, Associated British Foods PLC, IMCD NV, Clariant AG, Evonik Industries AG, Colorcon, Sigachi, Spectrum Chemical Manufacturingrp, Roquette America, DFE Pharma, J. Rettenmaier & Söhne


Other key industry trends

  • In terms of revenue, Germany accounted for 7.6% of the global biopharmaceutical excipients market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany biopharmaceutical excipients market is projected to lead the regional market in terms of revenue in 2030.
  • Italy is the fastest growing regional market in Europe and is projected to reach USD 157.2 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Biopharmaceutical Excipients Market Companies

Name Profile # Employees HQ Website

Germany biopharmaceutical excipients market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharmaceutical excipients market will help companies and investors design strategic landscapes.


Carbohydrates was the largest segment with a revenue share of 35.75% in 2023. Horizon Databook has segmented the Germany biopharmaceutical excipients market based on specialty excipients/others, solubilizes & surfactants/emulsifiers, polyols, carbohydrates covering the revenue growth of each sub-segment from 2018 to 2030.


Germany has generated highest revenue in the Europe biopharmaceutical excipients market in 2018 and has maintained this trend throughout the forecast period. This is attributed to its strong position in the European pharmaceutical market responsible for approximately 23% of the same while ranking third globally.

The Drug Commission of the German Medical Association announced in 2008 that biosimilars can be considered as potent therapeutic alternative. Increasing number of physicians becoming primary users of biosimilars have propelled the demand for the same in Germany.

Reasons to subscribe to Germany biopharmaceutical excipients market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Germany biopharmaceutical excipients market databook

  • Our clientele includes a mix of biopharmaceutical excipients market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Germany biopharmaceutical excipients market , including forecasts for subscribers. This country databook contains high-level insights into Germany biopharmaceutical excipients market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Germany biopharmaceutical excipients market size, by product, 2018-2030 (US$M)

Germany Biopharmaceutical Excipients Market Outlook Share, 2023 & 2030 (US$M)

Germany biopharmaceutical excipients market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more